(Q37988153)

26 August 2017

title

Alpha-1-antitrypsin and other proteinase inhibitors (English)

1 reference

26 August 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A22365503

25 December 2024

1

Marc Miravitlles

1 reference

26 August 2017

language of work or name

1 reference

23 February 2012

1 reference

full work available at URL

26 August 2017

https://api.elsevier.com/content/article/PII:S1471489212000276?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/J.COPH.2012.02.004

https://api.elsevier.com/content/article/PII:S1471489212000276?httpAccept=text/plain

25 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.COPH.2012.02.004

Current Opinion in Pharmacology

25 December 2024

published in

1 reference

26 August 2017

volume

12

1 reference

26 August 2017

issue

3

1 reference

26 August 2017

page(s)

309-314

1 reference

Prevalence of COPD in Spain: impact of undiagnosed COPD on quality of life and daily life activities

26 August 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1016/J.COPH.2012.02.004

American Thoracic Society/European Respiratory Society statement: standards for the diagnosis and management of individuals with alpha-1 antitrypsin deficiency

25 December 2024

2

1 reference

https://api.crossref.org/works/10.1016/J.COPH.2012.02.004

Role of human neutrophil peptides in lung inflammation associated with α1-antitrypsin deficiency

25 December 2024

3

1 reference

https://api.crossref.org/works/10.1016/J.COPH.2012.02.004

Alpha1-antitrypsin deficiency. 4: Molecular pathophysiology

25 December 2024

4

1 reference

https://api.crossref.org/works/10.1016/J.COPH.2012.02.004

Alpha1-antitrypsin deficiency

25 December 2024

5

1 reference

https://api.crossref.org/works/10.1016/J.COPH.2012.02.004

The Degradome database: mammalian proteases and diseases of proteolysis

25 December 2024

6

1 reference

https://api.crossref.org/works/10.1016/J.COPH.2012.02.004

Proteases: multifunctional enzymes in life and disease

25 December 2024

7

1 reference

https://api.crossref.org/works/10.1016/J.COPH.2012.02.004

Augmentation therapy for emphysema due to alpha-1-antitrypsin deficiency

25 December 2024

8

1 reference

https://api.crossref.org/works/10.1016/J.COPH.2012.02.004

Inhibition of human granulocyte elastase by serum alpha-1-antitrypsin

25 December 2024

9

1 reference

https://api.crossref.org/works/10.1016/J.COPH.2012.02.004

Diagnóstico y tratamiento del déficit de alfa-1-antitripsina

25 December 2024

10

1 reference

https://api.crossref.org/works/10.1016/J.COPH.2012.02.004

Replacement therapy for alpha 1-antitrypsin deficiency associated with emphysema

25 December 2024

11

1 reference

https://api.crossref.org/works/10.1016/J.COPH.2012.02.004

Augmentation therapy in alpha-1 antitrypsin deficiency: advances and controversies

25 December 2024

12

1 reference

https://api.crossref.org/works/10.1016/J.COPH.2012.02.004

Augmentation therapy with alpha1-antitrypsin: patterns of use and adverse events

25 December 2024

13

1 reference

https://api.crossref.org/works/10.1016/J.COPH.2012.02.004

Alpha-1-antitrypsin deficiency: optimal therapeutic regimen based on population pharmacokinetics

25 December 2024

14

1 reference

https://api.crossref.org/works/10.1016/J.COPH.2012.02.004

Factors associated with the evolution of lung function in patients with alpha-1 antitrypsin deficiency in the Spanish registry

25 December 2024

15

1 reference

https://api.crossref.org/works/10.1016/J.COPH.2012.02.004

A randomized clinical trial of alpha(1)-antitrypsin augmentation therapy

25 December 2024

16

1 reference

https://api.crossref.org/works/10.1016/J.COPH.2012.02.004

Exploring the role of CT densitometry: a randomised study of augmentation therapy in alpha1-antitrypsin deficiency

25 December 2024

17

1 reference

https://api.crossref.org/works/10.1016/J.COPH.2012.02.004

Therapeutic efficacy of alpha-1 antitrypsin augmentation therapy on the loss of lung tissue: an integrated analysis of 2 randomised clinical trials using computed tomography densitometry

25 December 2024

18

1 reference

https://api.crossref.org/works/10.1016/J.COPH.2012.02.004

alpha1-Antitrypsin augmentation therapy for PI*MZ heterozygotes: a cautionary note.

25 December 2024

19

1 reference

https://api.crossref.org/works/10.1016/J.COPH.2012.02.004

A novel oral neutrophil elastase inhibitor (ONO-6818) inhibits human neutrophil elastase-induced emphysema in rats

25 December 2024

20

1 reference

https://api.crossref.org/works/10.1016/J.COPH.2012.02.004

Targeting COPD: advances on low‐molecular‐weight inhibitors of human neutrophil elastase

25 December 2024

21

1 reference

https://api.crossref.org/works/10.1016/J.COPH.2012.02.004

The dietary phytochemical indole-3-carbinol is a natural elastase enzymatic inhibitor that disrupts cyclin E protein processing

25 December 2024

23

1 reference

https://api.crossref.org/works/10.1016/J.COPH.2012.02.004

Emerging pharmacotherapies for COPD.

25 December 2024

24

1 reference

https://api.crossref.org/works/10.1016/J.COPH.2012.02.004

Effect of an MMP-9/MMP-12 inhibitor on smoke-induced emphysema and airway remodelling in guinea pigs

25 December 2024

25

1 reference

https://api.crossref.org/works/10.1016/J.COPH.2012.02.004

Long-term augmentation therapy in twenty patients with severe alpha-1-antitrypsin deficiency--three-year follow-up

25 December 2024

26

1 reference

https://api.crossref.org/works/10.1016/J.COPH.2012.02.004

Long-term treatment of alpha1-antitrypsin deficiency-related pulmonary emphysema with human alpha1-antitrypsin. Wissenschaftliche Arbeitsgemeinschaft zur Therapie von Lungenerkrankungen (WATL)-alpha1-AT-study group

25 December 2024

28

1 reference

https://api.crossref.org/works/10.1016/J.COPH.2012.02.004

Replacement therapy for hereditary alpha1-antitrypsin deficiency. A program for long-term administration

25 December 2024

29

1 reference

https://api.crossref.org/works/10.1016/J.COPH.2012.02.004

[Evaluation of replacement therapy in emphysema caused by alpha 1-antitrypsin deficiency]

25 December 2024

30

1 reference

https://api.crossref.org/works/10.1016/J.COPH.2012.02.004

Intravenous human plasma-derived augmentation therapy in alpha 1-antitrypsin deficiency: from pharmacokinetic analysis to individualizing therapy

25 December 2024

32

1 reference

https://api.crossref.org/works/10.1016/J.COPH.2012.02.004

Tailored pharmacokinetic dosing allows self-administration and reduces the cost of IV augmentation therapy with human alpha(1)-antitrypsin

25 December 2024

33

1 reference

https://api.crossref.org/works/10.1016/J.COPH.2012.02.004

Does alpha1-antitrypsin augmentation therapy slow the annual decline in FEV1 in patients with severe hereditary alpha1-antitrypsin deficiency? Wissenschaftliche Arbeitsgemeinschaft zur Therapie von Lungenerkrankungen (WATL) alpha1-AT study group

25 December 2024

34

1 reference

https://api.crossref.org/works/10.1016/J.COPH.2012.02.004

Survival and FEV1 decline in individuals with severe deficiency of alpha1-antitrypsin. The Alpha-1-Antitrypsin Deficiency Registry Study Group

25 December 2024

35

1 reference

https://api.crossref.org/works/10.1016/J.COPH.2012.02.004

Short-term supplementation therapy does not affect elastin degradation in severe alpha(1)-antitrypsin deficiency. The American-Italian AATD Study Group

25 December 2024

36

1 reference

https://api.crossref.org/works/10.1016/J.COPH.2012.02.004

Augmentation therapy reduces frequency of lung infections in antitrypsin deficiency: a new hypothesis with supporting data

25 December 2024

37

1 reference

https://api.crossref.org/works/10.1016/J.COPH.2012.02.004

Longitudinal follow-up of patients with alpha(1)-protease inhibitor deficiency before and during therapy with IV alpha(1)-protease inhibitor

25 December 2024

38

1 reference

https://api.crossref.org/works/10.1016/J.COPH.2012.02.004

The effect of augmentation therapy on bronchial inflammation in alpha1-antitrypsin deficiency

25 December 2024

39

1 reference

https://api.crossref.org/works/10.1016/J.COPH.2012.02.004

alpha1-Antitrypsin deficiency . 5: intravenous augmentation therapy: current understanding

25 December 2024

40

1 reference

https://api.crossref.org/works/10.1016/J.COPH.2012.02.004

25 December 2024

Identifiers

1 reference

26 August 2017

1 reference